ReviewTropical medicine and health2026
Neurological complications of Zika virus and their impact on quality of life: a narrative review.
Review in Tropical medicine and health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundZika virus (ZIKV), known for its alarming health consequences, is primarily transmitted by infected Aedes spp. mosquitoes but can also spread through sexual contact and from mother to child during pregnancy. While most infections are mild or asymptomatic, ZIKV has been linked to severe neurological disorders, such as Guillain-Barré syndrome (GBS) in adults and congenital Zika syndrome (CZS) in infants. While the substantial economic burden and the range of these disorders have been described, the potential long-term effects and the impact on quality of life (QoL) remain inadequately understood, presenting challenges for both public health and clinical care. MAIN BODY: This narrative review describes the broader spectrum of neurological complications associated with ZIKV infection and explores their impact on the QoL of patients and caregivers, aiming to deepen the public and clinical understanding of the topic, which is crucial for developing effective prevention and treatment strategies. Beyond the established links to GBS and CZS, ZIKV has been associated with other neurological complications, such as encephalitis and myelitis, highlighting the complex clinical course of the disease. These neurological outcomes can lead to lifelong disabilities, profoundly affecting patients' and caregivers' QoL. Mothers of children with CZS may experience heightened anxiety, depression, and overall reduced QoL, while many individuals with GBS struggle to regain the QoL they had pre-illness.
conclusionsThe limited availability of high-quality data, primarily relying on case reports, highlights the need for more comprehensive research to establish clear causal links and better understand the long-term consequences of ZIKV-related neurological complications. Prioritizing research on long-term effects, management, and prevention strategies is crucial to improving patient outcomes and guiding future clinical care.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.